Cost effectiveness of fluticasone propionate and flunisolide in the treatment of corticosteroid-naive patients with moderate asthma.

This publication has 18 references indexed in Scilit:

• Asthma Pharmacotherapy: Current Practices and Outlook
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1997
• Impact of Fluticasone Propionate Powder on Health-Related Quality of Life in Patients with Moderate Asthma
  Journal of Asthma, 1997
• National Asthma Education and Prevention Program Working Group Report on the Cost Effectiveness of Asthma Care
  American Journal of Respiratory and Critical Care Medicine, 1996
• The costs of asthma
  European Respiratory Journal, 1996
• Costs and effects of inhaled corticosteroids and bronchodilators in asthma and chronic obstructive pulmonary disease.
  American Journal of Respiratory and Critical Care Medicine, 1995
• The ??2-Agonist Controversy
  Drug Safety, 1994
• The Cost per Treatment Success
  PharmacoEconomics, 1994
• An Economic Evaluation of Asthma in the United States
  New England Journal of Medicine, 1992
• Consequences of poor compliance in chronic respiratory diseases
  European Respiratory Journal, 1992
• Evaluation of the burden of illness for pediatric asthmatic patients and their parents.
  1991